top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
Autore Kazmierski Wieslaw M
Pubbl/distr/stampa Hoboken, : Wiley, 2011
Descrizione fisica 1 online resource (470 p.)
Disciplina 615/.7924
Soggetto topico Antiviral Agents -- therapeutic use
Antiviral agents
Clinical Trials as Topic
Drug Discovery
Drug Evaluation
Epidemiologic Studies
Chemistry, Pharmaceutical
Evaluation Studies as Topic
Investigative Techniques
Anti-Infective Agents
Epidemiologic Methods
Pharmacology
Therapeutic Uses
Health Care Evaluation Mechanisms
Chemistry
Biological Science Disciplines
Natural Science Disciplines
Quality of Health Care
Public Health
Pharmacologic Actions
Environment and Public Health
Health Care Quality, Access, and Evaluation
Chemical Actions and Uses
Health Care
Antiviral Agents
Health & Biological Sciences
Pharmacy, Therapeutics, & Pharmacology
ISBN 1-283-20363-4
9786613203632
0-470-92935-9
0-470-92934-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir
14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection
21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir
29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate
Record Nr. UNINA-9910139613803321
Kazmierski Wieslaw M  
Hoboken, : Wiley, 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
Autore Kazmierski Wieslaw M
Pubbl/distr/stampa Hoboken, : Wiley, 2011
Descrizione fisica 1 online resource (470 p.)
Disciplina 615/.7924
Soggetto topico Antiviral Agents -- therapeutic use
Antiviral agents
Clinical Trials as Topic
Drug Discovery
Drug Evaluation
Epidemiologic Studies
Chemistry, Pharmaceutical
Evaluation Studies as Topic
Investigative Techniques
Anti-Infective Agents
Epidemiologic Methods
Pharmacology
Therapeutic Uses
Health Care Evaluation Mechanisms
Chemistry
Biological Science Disciplines
Natural Science Disciplines
Quality of Health Care
Public Health
Pharmacologic Actions
Environment and Public Health
Health Care Quality, Access, and Evaluation
Chemical Actions and Uses
Health Care
Antiviral Agents
Health & Biological Sciences
Pharmacy, Therapeutics, & Pharmacology
ISBN 1-283-20363-4
9786613203632
0-470-92935-9
0-470-92934-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir
14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection
21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir
29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate
Record Nr. UNINA-9910808713803321
Kazmierski Wieslaw M  
Hoboken, : Wiley, 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiac resynchronization therapy for congestive heart failure : prepared for agency for healthcare research and quality
Cardiac resynchronization therapy for congestive heart failure : prepared for agency for healthcare research and quality
Pubbl/distr/stampa [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004
Collana Evidence report/technology assessment. Summary
AHRQ pub.
Soggetto topico Controlled Clinical Trials as Topic
Clinical Medicine
Electric Stimulation Therapy
Evidence-Based Practice
Heart Diseases
Clinical Trials as Topic
Cardiovascular Diseases
Medicine
Therapeutics
Health Occupations
Evaluation Studies as Topic
Epidemiologic Studies
Diseases
Diagnostic Techniques and Procedures
Health Care Evaluation Mechanisms
Epidemiologic Methods
Investigative Techniques
Public Health
Quality of Health Care
Environment and Public Health
Health Care Quality, Access, and Evaluation
Health Care
Evidence-Based Medicine
Randomized Controlled Trials as Topic
Cardiac Pacing, Artificial
Heart Failure
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910693974603321
[Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Criteria for distinguishing effectiveness from efficacy trials in systematic reviews
Criteria for distinguishing effectiveness from efficacy trials in systematic reviews
Pubbl/distr/stampa [Place of publication not identified], : Agency for Healthcare Research and Quality, 2006
Descrizione fisica 1 online resource
Disciplina 610.72/4
Collana Technical Reviews
AHRQ publication
Soggetto topico Epidemiologic Studies
Evaluation Studies as Topic
Epidemiologic Methods
Health Care Evaluation Mechanisms
Investigative Techniques
Public Health
Diagnostic Techniques and Procedures
Quality of Health Care
Environment and Public Health
Health Care Quality, Access, and Evaluation
Health Care
Clinical Trials as Topic
Medicine
Health & Biological Sciences
Medical Research
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910698279703321
[Place of publication not identified], : Agency for Healthcare Research and Quality, 2006
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Management of menopause-related symptoms
Management of menopause-related symptoms
Pubbl/distr/stampa [Place of publication not identified], : Agency for Healthcare Research and Quality U S Dept of Health and Human Services, 2005
Descrizione fisica 1 online resource
Disciplina 362.198/175
Collana Evidence report/technology assessment Management of menopause-related symptoms
Soggetto topico Menopause - Treatment
Evidence-based medicine
Clinical Medicine
Epidemiologic Studies
Investigative Techniques
Evidence-Based Practice
Pathological Conditions, Signs and Symptoms
Hormone Replacement Therapy
Climacteric
Sexual Development
Health Occupations
Medicine
Drug Therapy
Diseases
Reproductive Physiological Phenomena
Health Care Evaluation Mechanisms
Epidemiologic Methods
Therapeutics
Reproductive Physiological Processes
Reproductive and Urinary Physiological Phenomena
Quality of Health Care
Public Health
Environment and Public Health
Health Care Quality, Access, and Evaluation
Health Care
Cohort Studies
Cross-Sectional Studies
Estrogen Replacement Therapy
Methods
Menopause
Signs and Symptoms
Evidence-Based Medicine
Health & Biological Sciences
Gynecology & Obstetrics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910693974403321
[Place of publication not identified], : Agency for Healthcare Research and Quality U S Dept of Health and Human Services, 2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Prevention of urinary and fecal incontinence in adults
Prevention of urinary and fecal incontinence in adults
Pubbl/distr/stampa [Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2007
Descrizione fisica 1 online resource
Collana Evidence report/technology assessment Prevention of urinary and fecal incontinence in adults
Soggetto topico Urinary incontinence - Prevention
Fecal incontinence - Prevention
Evidence-based medicine
Risk
Epidemiologic Studies
Evidence-Based Practice
Rectal Diseases
Causality
Clinical Medicine
Urination Disorders
Urological Manifestations
Epidemiologic Methods
Urologic Diseases
Health Occupations
Health Care Evaluation Mechanisms
Probability
Epidemiologic Factors
Intestinal Diseases
Medicine
Signs and Symptoms
Statistics as Topic
Quality of Health Care
Male Urogenital Diseases
Pathological Conditions, Signs and Symptoms
Female Urogenital Diseases
Gastrointestinal Diseases
Public Health
Investigative Techniques
Environment and Public Health
Health Care Quality, Access, and Evaluation
Digestive System Diseases
Female Urogenital Diseases and Pregnancy Complications
Diagnostic Techniques and Procedures
Diseases
Health Care
Fecal Incontinence
Evidence-Based Medicine
Risk Factors
Urinary Incontinence
Health & Biological Sciences
Urology & Nephrology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910698356103321
[Place of publication not identified], : U S Dept of Health and Human Services Public Health Service Agency for Healthcare Research and Q, 2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Update on acute bacterial rhinosinusitis
Update on acute bacterial rhinosinusitis
Pubbl/distr/stampa [Place of publication not identified], : Agency for Healthcare Research and Quality, 2005
Descrizione fisica 1 online resource
Disciplina 616.2/12
Collana Evidence Reports/Technology Assessments
AHRQ publication
Soggetto topico Controlled Clinical Trials as Topic
Respiratory Tract Infections
Bacterial Infections and Mycoses
Disease Attributes
Paranasal Sinus Diseases
Diseases
Clinical Trials as Topic
Nose Diseases
Respiratory Tract Diseases
Pathologic Processes
Epidemiologic Studies
Otorhinolaryngologic Diseases
Evaluation Studies as Topic
Pathological Conditions, Signs and Symptoms
Epidemiologic Methods
Investigative Techniques
Health Care Evaluation Mechanisms
Quality of Health Care
Diagnostic Techniques and Procedures
Public Health
Health Care Quality, Access, and Evaluation
Environment and Public Health
Health Care
Randomized Controlled Trials as Topic
Bacterial Infections
Sinusitis
Acute Disease
Medicine
Health & Biological Sciences
Otorhinolaryngology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910693953603321
[Place of publication not identified], : Agency for Healthcare Research and Quality, 2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui